Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Alibaba Debuts Shares In Hong Kong: BABA Implications

Published 11/20/2019, 12:26 AM
Updated 07/09/2023, 06:31 AM
AMZN
-
BABA
-

China’s largest e-commerce player just executed an equity offering in one of the most chaotic cities in the world right now. Alibaba (NYSE:BABA) just issued roughly $13 billion in stock and executable options on the Hong Kong exchange in a global offering. Individual investors were able to get in on the action and placed more than 40 times as many shares as they were initially offered, according to the WSJ article.

This demonstrates an enormous amount of confidence in China’s Amazon (NASDAQ:AMZN) of the East. Alibaba is planning on using the funds to further build out its product offering beyond online shopping like cloud computing and digital media, following in Amazon’s footsteps.

The Business

Alibaba’s primary revenue driver is its domestic commerce retail, which makes up 64% of its income and grew at a sizable 40% in its latest September quarter earnings. International commerce only makes up 7% of the firm’s total revenue, but there is still an enormous amount of growth opportunity in the markets abroad.

Alibaba has been slowly building out its cloud computing, digital media, and entertainment product offerings as these capabilities have become in demand globally. Alibaba Cloud is growing fast with year-over-year increases in the high double-digits to triple-digit percentages since it went online in 2014. The segment is still not profitable, but like any growing business, it is gaining market share and international traction.

The recent trade war hasn’t appeared to have materially hampered business performance for the enterprise, and BABA continues to drive returns for investors. China’s economy is slowing down, and the trade war is a significant catalyst. The fact that Alibaba has still been able to return investors over 35% year-to-date illustrates the firm’s impervious growth. As you can see below, BABA has been able to outperform its American competitor, AMZN.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

BABA vs. AMZN

Alibaba may be smaller than Amazon, but it is right on its coattails. China is expected to be the largest consumer market in the world by the end of this year, and Alibaba has secure domination of this market and a share that continues to expand.

BABA is also able to achieve much stronger margins than AMZN and is actually more profitable than America’s favorite shopping site. Alibaba is expected to grow its topline at a substantial premium to Amazon’s, and with its leaner operations, it will continue to gain on them.

Right now, BABA is trading at a considerable discount to AMZN. Below you can see the PEG ratio of each company, representing the comparable forward P/E valuation of each stock accounting for growth.

As long as China’s consumer market doesn’t fall apart, I have confidence that BABA will outperform AMZN in the years to come. A trade war resolution will prove to have a much larger upside to BABA.

Take Away

Alibaba is hot right now, and its latest oversubscribed debut on the Hong Kong exchange illustrates this. This stock has a lot of upside potential, with the looming trade war being the only hampering its surge. Investors are still nervous about the economic slowdown in China and are pricing BABA accordingly. Analysts are considering this stock to be high risk, but its resilience to the trade war thus far gives me confidence in its ability to continue expanding.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Amazon.com, Inc. (AMZN): Free Stock Analysis Report

Alibaba Group Holding Limited (BABA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.